Archive for January, 2005



FDA’s goal is to improve the process for bringing safe and effective drugs for potentially serious and life-threatening diseases, such as cancer, heart disease and neurological disorders, to the market.

The U.S. Food and Drug Administration (FDA) is warning healthcare professionals and consumers that filling their prescriptions abroad may have adverse health consequences because of confusion with drug brand names that could inadvertently lead consumers to take the wrong medication for their condition.




About

You are currently browsing the Regulatory Affairs Syndicator weblog archives for January, 2005.

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories